Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11498966 PD-1 and PD-L1 binding agents

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 15, 2022

Patent Application Number

16636501

Date Filed

August 8, 2018

Patent Citations

US Patent 10407480 Targeted modified TNF family members

US Patent 10072059 Targeting of human interferon antagonists

US Patent 10640542 Fusokines involving cytokines with strongly reduced receptor binding affinities

US Patent 10034919 Targeted human-interferon fusion proteins

US Patent 10035835 Targeted modified TNF family members

Patent Primary Examiner

Elly-Gerald Stoica

The present invention relates, in part, to agents that bind PD-1 or PD-L1 and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the PD-1 or PD-L1 binding agents and their use in the treatment of various diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11498966 PD-1 and PD-L1 binding agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool